Filing Details
- Accession Number:
- 0001209191-17-035151
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-05-24 19:57:23
- Reporting Period:
- 2017-05-22
- Filing Date:
- 2017-05-24
- Accepted Time:
- 2017-05-24 19:57:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1560241 | G1 Therapeutics Inc. | GTHX | () | DE |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1291884 | Medimmune Ventures, Inc. | C/O G1 Therapeutics, Inc. 79 T.w. Alexander Drive Research Triangle Park NC 27709 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-05-22 | 3,409,536 | $0.00 | 3,409,536 | No | 4 | C | Direct | |
| Common Stock | Acquisiton | 2017-05-22 | 75,000 | $15.00 | 3,484,536 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | C | Direct | |
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Series A Preferred Stock | Disposition | 2017-05-22 | 7,142,857 | $0.00 | 2,380,952 | $0.00 |
| Common Stock | Series B Preferred Stock | Disposition | 2017-05-22 | 2,412,628 | $0.00 | 804,208 | $0.00 |
| Common Stock | Series C Preferred Stock | Disposition | 2017-05-22 | 673,128 | $0.00 | 224,376 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct | ||
| 0 | No | 4 | C | Direct |
Footnotes
- The Preferred Stock automatically converted into Common Stock upon the closing of the Issuer's initial public offering pursuant to the Issuer's Fifth Restated Certificate of Incorporation, as amended, based on the conversion rate in effect at the time of conversion. The Series A Preferred Stock, Series B Preferred Stock and Series C Preferred Stock converted to Common Stock on a 1-for-3 basis.
- Reflects shares the reporting person purchased in the initial public offering at the initial public offering price of $15.00 per share.
- The Series A Preferred Stock, Series B Preferred Stock and the Series C Preferred Stock automatically converted into shares of Common Stock upon consummation of the Issuer's initial public offering and had no expiration date.
Billionaire Hedge Funds
